Neuroendocrine tumor

Results: 292



#Item
1“New Paradigms That Increase Survival in Neuroendocrine Tumor Patients” Eugene A. Woltering MD FACS NOLANETSZEBRA = office

“New Paradigms That Increase Survival in Neuroendocrine Tumor Patients” Eugene A. Woltering MD FACS NOLANETSZEBRA = office

Add to Reading List

Source URL: www.cccsg.net

Language: English - Date: 2012-09-09 13:26:19
    2ORIGINAL ARTICLE Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients Eugene A. Woltering, MD, FACS,* Vergilio A. Salvo, MD,* Thomas M. O_D

    ORIGINAL ARTICLE Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients Eugene A. Woltering, MD, FACS,* Vergilio A. Salvo, MD,* Thomas M. O_D

    Add to Reading List

    Source URL: www.interscienceinstitute.com

    Language: English - Date: 2009-09-25 15:15:22
    3J. Vet. Med. A 36, 1989 Paul Parey Scientific Publishers, Berlin and Hamburg ISSN184X Department of Veterinary Pathology2, University of Utrecht, The Netherlands, Department of Veterinary Patholo

    J. Vet. Med. A 36, 1989 Paul Parey Scientific Publishers, Berlin and Hamburg ISSN184X Department of Veterinary Pathology2, University of Utrecht, The Netherlands, Department of Veterinary Patholo

    Add to Reading List

    Source URL: www.histopatovet.com

    Language: English - Date: 2014-05-11 17:25:56
    4ORIGINAL ARTICLE Validation of Neurokinin A Assays in the United States and Europe Paris Mamikunian,* Joy E. Ardill, PhD,Þ Thomas M. O’Dorisio, MD,þ Siegfried R. Krutzik, PhD,* Aaron I. Vinik, MD, PhD,§ Vay Liang W

    ORIGINAL ARTICLE Validation of Neurokinin A Assays in the United States and Europe Paris Mamikunian,* Joy E. Ardill, PhD,Þ Thomas M. O’Dorisio, MD,þ Siegfried R. Krutzik, PhD,* Aaron I. Vinik, MD, PhD,§ Vay Liang W

    Add to Reading List

    Source URL: www.interscienceinstitute.com

    Language: English - Date: 2011-09-26 15:15:19
    5JOBNAME: pan 31#PAGE: 1 OUTPUT: Wednesday October 19 08:24:lww/panMPA200087 ORIGINAL ARTICLE Effect of Octreotide LAR Dose and Weight on Octreotide

    JOBNAME: pan 31#PAGE: 1 OUTPUT: Wednesday October 19 08:24:lww/panMPA200087 ORIGINAL ARTICLE Effect of Octreotide LAR Dose and Weight on Octreotide

    Add to Reading List

    Source URL: www.interscienceinstitute.com

    Language: English - Date: 2009-09-25 15:15:26
    6

    PDF Document

    Add to Reading List

    Source URL: www.adacap.com

    Language: English - Date: 2016-08-02 07:01:40
    7EDITORIAL Serum Pancreastatin The Long Sought Universal, Sensitive, Specific Tumor Marker for Neuroendocrine Tumors? Tetsuhide Ito, MD, PhD,* Hisato Igarashi, MD, PhD,* and Robert T. Jensen, MDÞ

    EDITORIAL Serum Pancreastatin The Long Sought Universal, Sensitive, Specific Tumor Marker for Neuroendocrine Tumors? Tetsuhide Ito, MD, PhD,* Hisato Igarashi, MD, PhD,* and Robert T. Jensen, MDÞ

    Add to Reading List

    Source URL: www.interscienceinstitute.com

    Language: English - Date: 2012-07-02 15:25:47
    8AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas Tracey L. Smitha,b, Ziqiang Yuanc, Marina Cardó-Vilaa,b, Carmen Sanchez Clarosc, Asha Ademc, Min-Hui

    AAVP displaying octreotide for ligand-directed therapeutic transgene delivery in neuroendocrine tumors of the pancreas Tracey L. Smitha,b, Ziqiang Yuanc, Marina Cardó-Vilaa,b, Carmen Sanchez Clarosc, Asha Ademc, Min-Hui

    Add to Reading List

    Source URL: www.pnas.org

    Language: English - Date: 2016-02-25 21:33:54
    9March 2, 2016 PRESS RELEASE The International Neuroendocrine Cancer Alliance (INCA) Appoints First Executive Director

    March 2, 2016 PRESS RELEASE The International Neuroendocrine Cancer Alliance (INCA) Appoints First Executive Director

    Add to Reading List

    Source URL: incalliance.org

    Language: English - Date: 2016-03-02 07:43:31
    10ORIGINAL ARTICLE Validation of Serum Versus Plasma Measurements of Chromogranin A Levels in Patients With Carcinoid Tumors Lack of Correlation Between Absolute Chromogranin A Levels and Symptom Frequency

    ORIGINAL ARTICLE Validation of Serum Versus Plasma Measurements of Chromogranin A Levels in Patients With Carcinoid Tumors Lack of Correlation Between Absolute Chromogranin A Levels and Symptom Frequency

    Add to Reading List

    Source URL: www.interscienceinstitute.com

    Language: English - Date: 2012-12-06 13:48:28